We are developing a “tumor-targeted minimally invasive therapy” that improves the quality of life of cancer patients who cannot be treated by standard therapy. It is our mission to provide this new therapy as quickly as possible and to contribute to medical treatment with medical technology from Tokyo Tech.
“Tumor-targeted minimally invasive therapy” is a method in which an independently-developed tumor-insulating nanodevice (MD2) is locally administered to a tumor and specifically surrounds the tumor. It is a therapy that blocks oxygen and nutritional supply, thus having an antitumor effect. MD2 used in this therapy has biodegradability and will eventually be degraded in the body.
This therapy is being developed through collaborative research between the Company and Kondoh Laboratory at the Tokyo Institute of Technology Life Sciences Institute.
Company’s Keywords:
cancer, nanotechnology, medical devices, polymers
<0
<
<2013
Your request has been submitted successfully.
Own or work here?